EVANSTON, Ill., Oct. 9 /PRNewswire-FirstCall/ --
Northfield Laboratories Inc. (Nasdaq: NFLD), will host a conference call for
investors to provide an update on recent activities. Financial results for the
first quarter of 2003 will also be released on Wednesday, October 16, 2002
pre-market.
The company will broadcast its conference call over the Internet at
http://www.northfieldlabs.com or http://www.viavid.com on Wednesday, October 16, 2002, at
10:00 a.m. Central Time. Participants may also access the audio call by
dialing 888-881-4892 (domestic) or 416-640-4127 (international). Internet
participants should go to the website at least 15 minutes early to register,
download and install any necessary audio software. A replay of the call will
remain available at the site for 30 days.
"We are looking forward to updating our shareholders on our progress. We
appreciate the interest expressed in our recent news," said Steven A. Gould,
M.D., Chairman and Chief Executive Officer of Northfield.
Northfield Laboratories, founded in 1985, is a leading developer of an
oxygen-carrying blood substitute. Its product, PolyHeme(TM), is the only
blood substitute undergoing clinical trials that has been tested at large
enough dosages to be considered a substitute for acute blood loss in trauma
and surgical settings. As a result of the process used to manufacture the
blood substitute, essentially a solution of polymerized hemoglobin, PolyHeme
has a longer shelf life than blood, requires no cross matching and does not
transmit disease.
For further information on Northfield Laboratories, visit the website at
http://www.northfieldlabs.com
SOURCE Northfield Laboratories Inc.
 back to top
Related links:
http://www.northfieldlabs.com
CONTACT:
Steven A. Gould, M.D., Chief Executive
Officer or Sophia Twaddell, Investors, of Northfield
Laboratories, +1-847-864-3500, or Media, Cindy Martin of FRB
Weber Shandwick, +1-312-640-6741
|
